Safety of Celecoxib in patients with cutaneous reactions due to ASA-NSAIDs intolerance
Seguridad del celecoxib en pacientes con reacciones cutáneas por intolerancia a AAS-AINES
Read
7573
Timeswas read the article
939
Total PDF
6634
Total HTML
Article information
ISSN: 03010546Original language: English
DOI:10.1157/13108222
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 68 | 8 | 76 |
| 2024 October | 128 | 6 | 134 |
| 2024 September | 150 | 7 | 157 |
| 2024 August | 103 | 10 | 113 |
| 2024 July | 126 | 8 | 134 |
| 2024 June | 94 | 10 | 104 |
| 2024 May | 98 | 6 | 104 |
| 2024 April | 98 | 3 | 101 |
| 2024 March | 94 | 7 | 101 |
| 2024 February | 118 | 12 | 130 |
| 2024 January | 127 | 10 | 137 |
| 2023 December | 144 | 19 | 163 |
| 2023 November | 224 | 18 | 242 |
| 2023 October | 158 | 13 | 171 |
| 2023 September | 127 | 17 | 144 |
| 2023 August | 93 | 7 | 100 |
| 2023 July | 101 | 10 | 111 |
| 2023 June | 108 | 17 | 125 |
| 2023 May | 121 | 6 | 127 |
| 2023 April | 124 | 15 | 139 |
| 2023 March | 99 | 8 | 107 |
| 2023 February | 126 | 10 | 136 |
| 2023 January | 79 | 20 | 99 |
| 2022 December | 75 | 2 | 77 |
| 2022 November | 65 | 12 | 77 |
| 2022 October | 60 | 8 | 68 |
| 2022 September | 57 | 12 | 69 |
| 2022 August | 61 | 19 | 80 |
| 2022 July | 63 | 11 | 74 |
| 2022 June | 70 | 13 | 83 |
| 2022 May | 68 | 14 | 82 |
| 2022 April | 67 | 23 | 90 |
| 2022 March | 77 | 10 | 87 |
| 2022 February | 41 | 8 | 49 |
| 2022 January | 70 | 23 | 93 |
| 2021 December | 57 | 8 | 65 |
| 2021 November | 69 | 12 | 81 |
| 2021 October | 64 | 7 | 71 |
| 2021 September | 74 | 16 | 90 |
| 2021 August | 52 | 5 | 57 |
| 2021 July | 48 | 13 | 61 |
| 2021 June | 34 | 15 | 49 |
| 2021 May | 47 | 13 | 60 |
| 2021 April | 93 | 12 | 105 |
| 2021 March | 43 | 6 | 49 |
| 2021 February | 12 | 14 | 26 |
| 2021 January | 13 | 24 | 37 |
| 2020 December | 0 | 1 | 1 |
| 2020 November | 0 | 2 | 2 |
| 2020 May | 0 | 1 | 1 |
| 2020 March | 0 | 1 | 1 |
| 2019 June | 0 | 2 | 2 |
| 2019 May | 0 | 8 | 8 |
| 2019 April | 0 | 7 | 7 |
| 2018 February | 5 | 0 | 5 |
| 2018 January | 8 | 3 | 11 |
| 2017 December | 6 | 0 | 6 |
| 2017 November | 10 | 2 | 12 |
| 2017 October | 6 | 2 | 8 |
| 2017 September | 16 | 2 | 18 |
| 2017 August | 12 | 4 | 16 |
| 2017 July | 18 | 12 | 30 |
| 2017 June | 23 | 20 | 43 |
| 2017 May | 22 | 10 | 32 |
| 2017 April | 21 | 7 | 28 |
| 2017 March | 5 | 14 | 19 |
| 2017 February | 17 | 6 | 23 |
| 2017 January | 17 | 2 | 19 |
| 2016 December | 16 | 4 | 20 |
| 2016 November | 27 | 4 | 31 |
| 2016 October | 30 | 0 | 30 |
| 2016 September | 26 | 6 | 32 |
| 2016 August | 14 | 7 | 21 |
| 2016 July | 10 | 1 | 11 |
| 2016 June | 20 | 11 | 31 |
| 2016 May | 18 | 4 | 22 |
| 2016 April | 19 | 2 | 21 |
| 2016 March | 34 | 10 | 44 |
| 2016 February | 21 | 11 | 32 |
| 2016 January | 26 | 18 | 44 |
| 2015 December | 28 | 5 | 33 |
| 2015 November | 19 | 6 | 25 |
| 2015 October | 26 | 3 | 29 |
| 2015 September | 30 | 7 | 37 |
| 2015 August | 11 | 5 | 16 |
| 2015 July | 11 | 5 | 16 |
| 2015 June | 9 | 4 | 13 |
| 2015 May | 12 | 4 | 16 |
| 2015 April | 17 | 12 | 29 |
| 2015 March | 16 | 10 | 26 |
| 2015 February | 21 | 2 | 23 |
| 2015 January | 36 | 1 | 37 |
| 2014 December | 32 | 5 | 37 |
| 2014 November | 18 | 3 | 21 |
| 2014 October | 28 | 5 | 33 |
| 2014 September | 32 | 3 | 35 |
| 2014 August | 23 | 0 | 23 |
| 2014 July | 12 | 1 | 13 |
| 2014 June | 23 | 0 | 23 |
| 2014 May | 16 | 1 | 17 |
| 2014 April | 8 | 1 | 9 |
| 2014 March | 40 | 14 | 54 |
| 2014 February | 47 | 11 | 58 |
| 2014 January | 44 | 6 | 50 |
| 2013 December | 46 | 4 | 50 |
| 2013 November | 33 | 9 | 42 |
| 2013 October | 44 | 12 | 56 |
| 2013 September | 39 | 10 | 49 |
| 2013 August | 44 | 6 | 50 |
| 2013 July | 42 | 16 | 58 |
| 2013 June | 17 | 7 | 24 |
| 2013 May | 34 | 10 | 44 |
| 2013 April | 18 | 7 | 25 |
| 2013 March | 18 | 7 | 25 |
| 2013 February | 14 | 3 | 17 |
| 2013 January | 6 | 1 | 7 |
| 2012 November | 1 | 1 | 2 |
| 2012 October | 2 | 1 | 3 |
| 2007 June | 1182 | 0 | 1182 |
Show all
